Rapid and scalable human stem cell differentiation: Now in 3D

Stem Cells and Development

Volumn 22, Issue 20, 2013, Pages 2691-2692

  Hay, David C ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; CYTOCHROME P450; GLYCOGEN; INDOCYANINE GREEN; LOW DENSITY LIPOPROTEIN; UREA;

CELL DIFFERENTIATION; EDITORIAL; ENDODERM; ENGRAFTMENT; ENZYME ACTIVITY; GENE EXPRESSION; LIVER CELL; LIVER FUNCTION; MESODERM; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; SUSPENSION CELL CULTURE; TUMOR SPHEROID;

ANIMALS; CARBON TETRACHLORIDE; CELL CULTURE TECHNIQUES; CELL- AND TISSUE-BASED THERAPY; DRUG-INDUCED LIVER INJURY; HEPATOCYTES; MALE; PLURIPOTENT STEM CELLS;

EID: 84885153088     PISSN: 15473287     EISSN: 15578534     Source Type: Journal    
DOI: 10.1089/scd.2013.1500     Document Type: Editorial

References (20)

1. Duffield JS, SJ Forbes, CM Constandinou, S Clay, M Partolina, S Vuthoori, S Wu, R Lang and JP Iredale. (2005). Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair. J Clin Invest 115:56-65
2. Iredale JP. (2007). Models of liver fibrosis exploring the dynamic nature of inflammation and repair in a solid organ. J Clin Invest 117:539-548
3. Yang JD and LR Roberts. (2010). Hepatocellular carcinoma: A global view. Nat Rev Gastroenterol Hepatol 7:448-458
4. Miró JM, M Laguno, A Moreno, A Rimola; Hospital Clinic Olt In Hiv Working Group. (2006). Management of end stage liver disease (ESLD): What is the current role of orthotopic liver transplantation (OLT)? J Hepatol 44:S140-S145
5. Dhawan A, SC Strom, E Sokal and IJ Fox. (2010). Human hepatocyte transplantation. Methods Mol Biol 640:525-534
6. Chamuleau RA. (2009). Future of bioartificial liver support. World J Gastrointest Surg 1:21-25
7. Boulter L, O Govaere, TG Bird, S Radulescu, P Ramachandran, A Pellicoro, RA Ridgway, SS Seo, B Spee, et al. (2012). Macrophage-derived Wnt opposes Notch signaling to specify hepatic progenitor cell fate in chronic liver disease. Nat Med 18:572-579
8. Thomas JA, C Pope, D Wojtacha, AJ Robson, TT Gordon- Walker, S Hartland, P Ramachandran, M Van Deemter, DA Hume, JP Iredale and SJ Forbes. (2011). Macrophage therapy for murine liver fibrosis recruits host effector cells improving fibrosis, regeneration, and function. Hepatology 53:2003-2015
9. Szkolnicka D, W Zhou, B Lucendo-Villarin and DC Hay. (2013). Pluripotent stem-cell-derived hepatocytes: potential and challenges. Annu Rev Pharmacol Toxicol 53:147-159
10. Medine CN, B Lucendo-Villarin, C Storck, F Wang, D Szkolnicka, F Khan, S Pernagallo, JR Black, HM Marriage, et al. (2013). Developing high fidelity hepatotoxicity models from pluripotent stem cells. Stem Cells Trans Med 2:505- 509
11. Zhou W, Z Hannoun, E Jaffray, CN Medine, JR Black, S Greenhough, L Zhu, JA Ross, S Forbes, et al. (2012). SUMOylation of HNF4a regulates protein stability and hepatocyte function. J Cell Sci 125:3630-3635
12. Takahashi K and S Yamanaka. (2006). Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126:663-676
13. Takahashi K, K Tanabe, M Ohnuki, M Narita, T Ichisaka, K Tomoda and S Yamanaka. (2007). Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131:861-872
14. Olmer R, A Haase, S Merkert, W Cui, J Palecek, C Ran, A Kirschning, T Scheper, S Glage, et al. (2010). Long term expansion of undifferentiated human iPS and ES cells in suspension culture using a defined medium. Stem Cell Res 5:51-64
15. Singh H, P Mok, T Balakrishnan, SN Rahmat and R Zweigerdt. (2010). Up-scaling single cell-inoculated suspension culture of human embryonic stem cells. Stem Cell Res 4: 165-179
16. Larijani MR, A Seifinejad, B Pournasr, V Hajihoseini, SN Hassani, M Totonchi, M Yousefi, F Shamsi, GH Salekdeh and H Baharvand. (2011). Long-term maintenance of undifferentiated human embryonic and induced pluripotent stem cells in suspension. Stem Cells Dev 20:1911-1923
17. Abbasalizadeh S, MR Larijani, A Samadian and H Baharvand. (2012). Bioprocess development for mass production of size-controlled human pluripotent stem cell aggregates in stirred suspension bioreactor. Tissue Eng Part C Methods 18:831-851
18. Vosough M, E Omidinia, M Kadivar, MA Shokrgozar, B Pournasr, N Aghdami and H Baharvand. (2013). Generation of functional hepatocyte-like cells from human pluripotent stem cells in a scalable suspension culture. Stem Cells Dev Jun 3. [Epub ahead of print]
19. Yusa K, ST Rashid, H Strick-Marchand, I Varela, PQ Liu, DE Paschon, E Miranda, A Ordóñez, NR Hannan, et al. (2011). Targeted gene correction of a1-antitrypsin deficiency in induced pluripotent stem cells. Nature 478:391-394
20. Payne CM, K Samuel, A Pryde, J King, D Brownstein, J Schrader, CN Medine, SJ Forbes, JP Iredale, PN Newsome and DC Hay. (2011). Persistence of functional hepatocytelike cells in immune-compromised mice. Liver Int 31: 254-262